High Tower Advisors, LLC Atai Life Sciences N.V. Transaction History
High Tower Advisors, LLC
- $71.3 Billion
- Q1 2025
A detailed history of High Tower Advisors, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, High Tower Advisors, LLC holds 27,331 shares of ATAI stock, worth $112,877. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,331
Previous 30,462
10.28%
Holding current value
$112,877
Previous $40,000
7.5%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ATAI
# of Institutions
106Shares Held
23.4MCall Options Held
351KPut Options Held
170K-
Ubs Group Ag5.54MShares$22.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.29MShares$13.6 Million0.0% of portfolio
-
Pale Fire Capital Se Prague, 2N2.59MShares$10.7 Million0.42% of portfolio
-
Davidson Kempner Capital Management LP New York, NY1.41MShares$5.84 Million0.07% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$5.4 Million0.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $685M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...